연구동향 분석

ORIGINAL ARTICLE : Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension

( Byung Ju Kang ) ( Yeon Mok Oh ) ( Sang Do Lee ) ( Jae Seung Lee ) 2015년

논문상세정보
인용/피인용
' ORIGINAL ARTICLE : Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • anticoagulants
  • hypertension
  • korea
  • pulmonary
  • survival
  • warfarin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,365 0

0.0%

' ORIGINAL ARTICLE : Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension' 의 참고문헌

  • Updated clinical classification of pulmonary hypertension
    Simonneau G J Am Coll Cardiol 62 (25 Suppl) : D34 ~ D41 [2009]
  • Thrombotic arteriopathy and anticoagulation in pulmonary hypertension
    Johnson SR Chest 130 : 545 ~ 552 [2006]
  • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    Rich S N Engl J Med 327 : 76 ~ 81 [1992]
  • The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension
    Frank H Chest 112 : 714 ~ 721 [1997]
  • Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
    D’Alonzo GE Ann Intern Med 115 : 343 ~ 349 [1991]
  • Standardization of spirometry, 1994 update
    American Thoracic Society Am J Respir Crit Care Med 152 : 1107 ~ 1136 [1995]
  • Standardization of lung function testing in infants, children and adolescents
    Paediatric Working Group Bull Eur Physiopathol Respir 19 : 15P ~ 24P [1983]
  • Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension
    Shiran H J Am Soc Echo-cardiogr 27 : 405 ~ 412 [2014]
  • Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension
    Jing ZC Chest 132 : 373 ~ 379 [2007]
  • Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
    Lang RM J Am Soc Echocardiogr 18 : 1440 ~ 1463 [2005]
  • Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry
    Badesch DB Chest 137 : 376 ~ 387 [2010]
  • Pulmonary arterial hypertension in France : results from a national registry
    Humbert M Am J Respir Crit Care Med 173 : 1023 ~ 1030 [2006]
  • Primary pulmonary hypertension: natural history and the importance of thrombosis
    Fuster V Circulation 70 : 580 ~ 587 [1984]
  • Primary pulmonary hypertension: a national prospective study
    Rich S Ann Intern Med 107 : 216 ~ 223 [1987]
  • Primary pulmonary hypertension with emphasis on its etiology and treatment
    Storstein O Acta Med Scand 179 : 197 ~ 212 [1966]
  • Pilot study of shortterm effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension
    Ikeda D Circ J 71 : 1829 ~ 1831 [2007]
  • Normal predicted values of single-breath diffusing capacity of the lung in healthy nonsmoking adults
    Park JO Korean J Intern Med 1 : 178 ~ 184 [1986]
  • New predictors of outcome in idiopathic pulmonary arterial hypertension
    Kawut SM Am J Cardiol 95 : 199 ~ 203 [2005]
  • New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure
    Chemla D Chest 126 : 1313 ~ 1317 [2004]
  • Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension
    Huber K Am J Respir Crit Care Med 150 : 929 ~ 933 [1994]
  • Epidemiology of pulmonary hypertension: new data from the Swiss registry
    Tueller C Swiss Med Wkly 138 : 379 ~ 384 [2008]
  • Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension
    Ogata M Jpn Circ J 57 : 63 ~ 69 [1993]
  • Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin
    Weber C J Clin Pharmacol 39 : 847 ~ 854 [1999]
  • Continuous wave Doppler determination of right ventricular pressure : a simultaneous Doppler-catheterization study in 127 patients
    Currie PJ J Am Coll Cardiol 6 : 750 ~ 756 [1985]
  • Clinico-hemodynamic study and treatment of 44 patients with primary pulmonary hypertension
    Roman A Med Clin (Barc) 118 : 761 ~ 766 [2002]
  • Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension
    Raffy O Circulation 93 : 484 ~ 488 [1996]
  • Anticoagulation and survival in pulmonary arterial hypertension:results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
    Olsson KM Circulation 129 : 57 ~ 65 [2014]
  • A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography
    Quinones MA Circulation 64 : 744 ~ 753 [1981]